Cannalyze is developing an AI-based database of lab-tested cannabis compounds in order to provide consumers, caregivers, growers, and dispensaries with access to data on each product's unique potential effects. By making compound data accessible, Cannalyze will enable dispensaries to show their customers how different products can work for them, while providing growers with product feedback from consumers as well as other insights and tools to help them better understand their customers' needs. Cannalyze can also assist caregivers in prescribing the correct strains for their patients by providing information about each product's profile of compounds, potential effects, and consumption recommendations.